SBIO Among Health Care ETFs
End-of-day Nov 12, 2026 · 33 Health care ETFs by YTD
Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −4.0% | +5.8% | +9.2% | −16.9% | +9.2% | +21.4% | +126.2% | +17.9% | +144.5% |
| Peer average | −1.7% | +1.7% | +5.8% | +4.3% | +21.7% | +26.7% | +69.8% | +26.0% | — |
| S&P 500 · VOO | −0.3% | +3.3% | −1.6% | −2.2% | +11.9% | +12.1% | +80.1% | +73.9% | — |
$45 of every $1,000 in SBIO is Oruka
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | ORKAOruka Therapeutics | Healthcare | 4.45% | $445.02 | 81K | $8.7M |
| 2 | MANEVeraDermics | Healthcare | 4.11% | $410.62 | 51K | $8.0M |
| 3 | CGONCG oncology | Healthcare | 4.03% | $403.37 | 108K | $7.9M |
| 4 | EWTXEdgewise Therapeutics | Healthcare | 3.24% | $323.78 | 133K | $6.3M |
| 5 | DNTHDianthus Therapeutics | Healthcare | 3.13% | $313.45 | 68K | $6.1M |
| 6 | TVTXTravere Therapeutics | Healthcare | 3.07% | $307.17 | 115K | $6.0M |
| 7 | DFTXDefinium Therapeutics | Healthcare | 2.90% | $290.21 | 164K | $5.7M |
| 8 | RLAYRelay Therapeutics | Healthcare | 2.71% | $271.28 | 268K | $5.3M |
| 9 | XENEXenon Pharmaceuticals | Healthcare | 2.56% | $255.91 | 119K | $5.0M |
| 10 | AMLXAmylyx Pharmaceuticals | Healthcare | 2.51% | $250.59 | 154K | $4.9M |
| 11 | VRDNViridian Therapeutics | Healthcare | 2.22% | $222.22 | 139K | $4.3M |
| 12 | TARSTarsus Pharmaceuticals | Healthcare | 2.11% | $211.42 | 54K | $4.1M |
| 13 | DYNDyne Therapeutics | Healthcare | 2.11% | $210.89 | 229K | $4.1M |
| 14 | IRONDisc Medicine | Healthcare | 2.10% | $209.82 | 47K | $4.1M |
| 15 | ACADACADIA Pharmaceuticals | Healthcare | 1.98% | $198.26 | 210K | $3.9M |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | ORKA | Oruka Therapeutics | 4.45% |
| 2 | MANE | VeraDermics | 4.11% |
| 3 | CGON | CG oncology | 4.03% |
| 4 | EWTX | Edgewise Therapeutics | 3.24% |
| 5 | DNTH | Dianthus Therapeutics | 3.13% |
| 6 | TVTX | Travere Therapeutics | 3.07% |
| 7 | DFTX | Definium Therapeutics | 2.90% |
| 8 | RLAY | Relay Therapeutics | 2.71% |
| 9 | XENE | Xenon Pharmaceuticals | 2.56% |
| 10 | AMLX | Amylyx Pharmaceuticals | 2.51% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 19, 2024 | Dec 26, 2024 | $1.17 |
| Dec 21, 2023 | Dec 27, 2023 | $0.0711 |
| Dec 19, 2019 | Dec 27, 2019 | $0.0160 |
| Dec 20, 2018 | Dec 27, 2018 | $0.78 |
| Dec 21, 2017 | Dec 28, 2017 | $0.58 |